Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on hormone replacement therapy.

R D Gambrell1

  • 1Department of Physiology and Endocrinology, Medical College of Georgia, Augusta.

American Family Physician
|November 11, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.

Climacteric : the journal of the International Menopause Society·2006
Same author

Physicians should provide moral leadership to their communities: Presidential address.

American journal of obstetrics and gynecology·2000
Same author

Estrogen replacement therapy in women with previous breast cancer.

American journal of obstetrics and gynecology·1999
Same author

Strategies to reduce the incidence of endometrial cancer in postmenopausal women.

American journal of obstetrics and gynecology·1997
Same author

Hormone replacement therapy and breast cancer risk.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·1996
Same author

Hormone replacement therapy and breast cancer risk.

Archives of family medicine·1996
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Hormone replacement therapy offers significant benefits for menopausal women, including symptom relief and disease prevention. Risks are manageable with proper medical guidance, and combined therapies may even reduce certain cancer risks.

Area of Science:

  • Endocrinology
  • Women's Health
  • Pharmacology

Background:

  • Hormone replacement therapy (HRT) is widely recognized for its benefits in managing menopausal symptoms and preventing associated health issues.
  • Key benefits include relief from vasomotor symptoms, psychogenic manifestations, and atrophic vaginitis.
  • HRT also plays a role in osteoporosis prevention and treatment, and potentially in cardiovascular disease prevention.

Purpose of the Study:

  • To review the established benefits of hormone replacement therapy (HRT).
  • To discuss the risks associated with HRT and strategies for minimization.
  • To examine the impact of combined estrogen and progestogen therapy on lipid levels, endometrial cancer, and breast cancer risk.

Main Methods:

  • Literature review of studies on hormone replacement therapy.

Related Experiment Videos

  • Analysis of data regarding the effects of estrogen and progestogen on physiological markers.
  • Examination of epidemiological data on cancer incidence and prognosis in HRT users.

    • Main Results:

    • HRT effectively alleviates menopausal symptoms and prevents conditions like osteoporosis and atrophic vaginitis.
    • Risks associated with HRT can be minimized through careful patient evaluation and appropriate hormone selection.
    • Combined estrogen and progestogen therapy does not adversely affect lipid levels and reduces endometrial cancer incidence.
    • The risk of breast cancer with HRT is debated, but estrogen therapy alone does not appear to increase it, and progestogen may offer protection for some women.

    Conclusions:

    • Hormone replacement therapy provides substantial benefits for postmenopausal women when managed appropriately.
    • Combined hormone therapy is associated with a reduced risk of endometrial cancer and potentially breast cancer.
    • HRT may improve the prognosis for women diagnosed with breast cancer.